Tiziana Life Sciences plc - Distribution Dates for shares and ADRs in Accustem Sciences Limited
July 02 2021 - 6:58AM
Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) ("Tiziana" or
the "Company"), a biotechnology company focused on innovative
therapeutics for oncology, inflammation and infectious diseases,
today announces that the Forms 20-F and F-6 filed by Accustem
Sciences Limited with the SEC have been declared effective,
enabling the completion of the in specie distribution and spin out
of Accustem Sciences Limited. These documents together can be found
at www.accustem.com
Times and dates for holders of Tiziana
ordinary shares (traded on the London Stock Exchange)
The timetable for the holders of Tiziana
ordinary shares (traded on the London Stock Exchange) held in CREST
and Certificated form is as follows:
Demerger
Record Time: |
7:00 a.m. on
30 October 2020 |
|
|
Ex-entitlement date for Accustem Shares: |
2 November 2020 |
|
|
CREST accounts credited with Accustem Shares: |
8 July 2021* |
|
|
Certificates for Accustem Shares for those shareholders holding
their Tiziana Life Sciences plc in certificated form: |
by 18 July 2021 |
|
|
* replacing allocation placeholders currently
showing |
Times and dates for holders of Tiziana
ADSs (traded on the US Nasdaq Market)
The timetable for the holders of Tiziana ADSs
(traded on the Nasdaq market) are subject to different corporate
action timings and holders of the ADRs should also refer to the
notice published today by JP Morgan, the ADR depositary bank which
can be found at https://www.adr.com/drprofile/88875G101
Announcement Tiziana CUSIP: 88875G101
Corporate
Action Type: |
Spin Off with
DR Distribution |
|
|
Spin Off Issuer Name: |
Accustem Sciences Limited |
|
|
Spin Off DR CUSIP: |
00442Y101 |
|
|
DR Distribution Rate: |
1 new Accustem DR(s) issued for every 1 existing Tiziana DR
held on DR Record Date |
|
|
Tax Withholding Rate: |
n/a |
|
|
DR Record Date: |
November 6, 2020 |
|
|
DR Payment Date: |
July 14, 2021 |
|
|
DR Issuance and Cancellation Books close Date:
October 28, 2020 |
|
|
DR Issuance and Cancellation Books reopen Date:
July 19, 2021 |
|
|
Fees: Issuance fee: $nil per DR issued |
The Issuer has announced a Spin Off Distribution
in the local market. Existing Tiziana DRs will continue to be valid
and will not have to be exchanged for new DRs.
For further enquiries:United
Kingdom: |
|
Tiziana Life Sciences plcGabriele Cerrone, Chairman and
founder |
+44 (0)20 7495 2379 |
United
States:Investors:Dave Gentry, CEORedChip
Companies Inc.1-800-RED-CHIP
(733-2447)or407-491-4498dave@redchip.com |
|
Tiziana Life Sciences (NASDAQ:TLSA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Tiziana Life Sciences (NASDAQ:TLSA)
Historical Stock Chart
From Jul 2023 to Jul 2024